Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy

References

• Smith A, Crouch S, Lax S, et al. Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network. Br J Cancer. 2015;112:1575–1584. doi:10.1038/bjc.2015.9425867256
   PubMed Web of Science ®Google Scholar
• Engholm G, Ferlay J, Christensen N, et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the nordic countries, Version 5.3. 4 25, 2013 Available from: http://www.ancr.nu Accessed 101, 2013.
   Google Scholar
• Moullet I, Salles G, Ketterer N, et al. Frequency and significance of anemia in non-Hodgkin’s lymphoma patients. Ann Oncol. 1998;9:1109–1115. doi:10.1023/a:10084987050329834824
   PubMed Web of Science ®Google Scholar
• Troppan KT, Melchardt T, Deutsch A, et al. The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients. Eur J Haematol. 2015;95:538–544. doi:10.3109/10428194.2013.80231425677782
   PubMed Web of Science ®Google Scholar
• Adams HJA, de Klerk JMH, Fijnheer R, et al. Prognostic value of anemia and c-reactive protein levels in diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk. 2015;15:671–679. doi:10.1016/j.clml.2015.07.63926361646
   PubMed Web of Science ®Google Scholar
• Tisi MC, Bozzoli V, Giachelia M, et al. Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. Leuk Lymphoma. 2014;55:270–275. doi:10.3109/10428194.2013.80231423647063
   PubMed Web of Science ®Google Scholar
• Zinzani PL, Tani M, Alinari L, et al. Role of anemia in survival of patients with elderly aggressive non-Hodgkin’s lymphoma after chemotherapy. Leuk Lymphoma. 2005;46:1449–1454. doi:10.1080/1042819050017868816194890
   PubMed Web of Science ®Google Scholar
• Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001;91:2214–2221.11413508
   PubMed Web of Science ®Google Scholar
• Ziepert M, Hasenclever D, Kuhnt E, et al. Standard international prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era. J Clin Oncol. 2010;28:2373–2380. doi:10.1200/JCO.2009.26.249320385988
   PubMed Web of Science ®Google Scholar
• Solal-Céligny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood. 2004;104:1258–1265. doi:10.1182/blood-2003-12-443415126323
   PubMed Web of Science ®Google Scholar
• Shipp MA. A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s lymphoma prognostic factors project. N Engl J Med. 1993;329:987–994. doi:10.1056/NEJM1993093032914028141877
   PubMed Web of Science ®Google Scholar
• Zhou Z, Sehn LH, Rademaker AW, et al. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood. 2014;123:837–842. doi:10.1182/blood-2013-09-52410824264230
   PubMed Web of Science ®Google Scholar
• Arboe B, Josefsson P, Jørgensen J, et al. Danish National Lymphoma Registry. Clin Epidemiol. 2016;8:577–581. doi:10.2147/CLEP.S9947027822102
   PubMed Web of Science ®Google Scholar
• Arboe B, El-Galaly TC, Clausen MR, et al. The Danish national lymphoma registry: coverage and data quality. PLoS One. 2016;11:e0157999. doi:10.1371/journal.pone.015799927336800
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449. doi:10.2147/CLEP26604824
   PubMed Web of Science ®Google Scholar
• Bjerregaard B, Larsen OB. The Danish Pathology Register. Scand J Public Health. 2011;39:72–74. doi:10.1177/140349481039356321775357
   PubMed Web of Science ®Google Scholar
• Grann AF, Erichsen R, Nielsen AG, Frøslev T, Thomsen R. Existing data sources for clinical epidemiology: the clinical laboratory information system (LABKA) research database at Aarhus University, Denmark. Clin Epidemiol. 2011;3:133. doi:10.2147/CLEP.S1790121487452
   PubMedGoogle Scholar
• Kotze SR, Pedersen OB, Petersen MS, et al. Predictors of hemoglobin in Danish blood donors: results from the Danish Blood Donor Study. Transfusion. 2015;55:1303–1311. doi:10.1111/trf.1301125647099
   PubMed Web of Science ®Google Scholar
• Nordin G, Mårtensson A, Swolin B, et al. A multicentre study of reference intervals for haemoglobin, basic blood cell counts and erythrocyte indices in the adult population of the Nordic countries. Scand J Clin Lab Invest. 2004;64:385–398. doi:10.1080/0036551041000279715223702
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–383. doi:10.1016/0021-9681(87)90171-83558716
   PubMedGoogle Scholar
• Nørgaard M, Larsson H, Pedersen G, Schønheyder HC, Sørensen HT. Haematological malignancies - a predictor of a poor outcome in patients with bacteraemia. J Infect. 2006;53:190–198. doi:10.1016/j.jinf.2005.10.02416352338
   PubMed Web of Science ®Google Scholar
• Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83. doi:10.1186/1471-2288-11-8321619668
   PubMed Web of Science ®Google Scholar
• Pedersen CB. The Danish civil registration system. Scand J Public Health. 2011;39:22–25. doi:10.1177/140349481038796521775345
   PubMed Web of Science ®Google Scholar
• Maurer MJ, Ghesquières H, Jais J-P, et al. Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. J Clin Oncol. 2014;32:1066–1073. doi:10.1200/JCO.2013.51.586624550425
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Link BK, Habermann TM, et al. Cohort profile: the lymphoma specialized program of research excellence (SPORE) molecular epidemiology resource (MER) cohort study. Int J Epidemiol. 2017;46:1753–1754i. doi:10.1093/ije/dyx11929025017
   PubMed Web of Science ®Google Scholar
• Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–282. doi:10.1182/blood-2003-05-154514504078
   PubMed Web of Science ®Google Scholar
• Cox D. Regression models and life tables. J R Stat Soc Ser B. 1972;34:187–220.
   Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481. doi:10.1080/01621459.1958.10501452
   Web of Science ®Google Scholar
• Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2006;25:127–141. doi:10.1002/sim.233116217841
   PubMed Web of Science ®Google Scholar
• Martinsson A, Andersson C, Andell P, Koul S, Engström G, Smith JG. Anemia in the general population: prevalence, clinical correlates and prognostic impact. Eur J Epidemiol. 2014;29:489–498. doi:10.1007/s10654-014-9929-924952166
   PubMed Web of Science ®Google Scholar
• Beesley LJ, Bartlett JW, Wolf GT, Taylor JMG. Multiple imputation of missing covariates for the Cox proportional hazards cure model. Stat Med. 2016;35:4701–4717. doi:10.1002/sim.704827439726
   PubMed Web of Science ®Google Scholar
• Benchimol EI, Smeeth L, Guttmann A, et al. The reporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12:e1001885. doi:10.1371/journal.pmed.100188526440803
   PubMed Web of Science ®Google Scholar
• Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573–577. doi:10.7326/0003-4819-147-8-200710160-0001017938396
   PubMed Web of Science ®Google Scholar
• Truong PT, Parhar T, Hart J, Alexander C, Wai ES. Population-based analysis of the frequency of anemia and its management before and during chemotherapy in patients with malignant lymphoma. Am J Clin Oncol. 2010;33:465–468. doi:10.1097/COC.0b013e3181b4b14719935386
   PubMed Web of Science ®Google Scholar
• Prosnitz RG, Yao B, Farrell CL, Clough R, Brizel DM. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 2005;61:1087–1095. doi:10.1016/j.ijrobp.2004.07.71015752888
   PubMed Web of Science ®Google Scholar
• Gupta M, Han JJ, Stenson M, et al. Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation. Blood. 2012;119:2844–2853. doi:10.1182/blood-2011-10-38853822323454
   PubMed Web of Science ®Google Scholar